-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/BnHj53HwgSBNXMvnyavxfS
January 26, 2016 - relationships, possible
adverse effects from treatment, cost of mental health and medi-
cal visits and medications
-
www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/perinatal-depression-preventive-interventions
February 12, 2019 - Data are lacking on the benefits and harms of antidepressant medications for the prevention of perinatal
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/drug-abuse-screening-1996
January 01, 1996 - False-positive results from urine drug screening are possible due to cross-reaction with other medications
-
www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-section-1
December 01, 2013 - preventive services, including screening tests, counseling about healthful behaviors, and preventive medications
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/gestational-diabetes-mellitus-screening-january-2014
January 14, 2014 - with preeclampsia are at risk for a cascade of interventions, including further monitoring, additional medications
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-dyslipidemia/statin-use-in-adults-preventive-medication-november-2016
November 13, 2016 - dyslipidemia in younger adults might enable management strategies, including lifestyle modification or medications
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/h-w99jVsodSL33kV2h2_qW
April 17, 2018 - adapta-
tion or modification of home environment; withdrawal or minimi-
zation of psychoactive or other medications
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary11/carotid-artery-stenosis-screening-december-2007
December 15, 2007 - More than 50% of the patients were receiving antihypertensive medications, but the achieved systolic
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/YSj5xRQc9DroH8gpUYsoFA
December 01, 2007 - More than 50% of the patients were
receiving antihypertensive medications, but the achieved
systolic
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZYao53-sqRb6oZzKzDmjjt
December 01, 2003 - orlistat-treated patients with diabetes were more
likely (17% vs 8%, P < 0.05) to decrease or
discontinue diabetes medications … In the latter trial, mean lactic acid values
did not rise.97 Prior review of other weight loss
medications … Medications — RCT (of fair or good quality) 10
— Outcome: weight loss or BMI reduction;
glucose tolerance
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obesity-in-adults-screening-and-counseling-2003
December 15, 2003 - diabetes were more likely (17 percent vs 8 percent, P < 0.05) to decrease or discontinue diabetes medications … In the latter trial, mean lactic acid values did not rise. 97 Prior review of other weight loss medications … Medications
- RCT (of fair or good quality)
- Outcome: weight loss or BMI reduction; glucose tolerance
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin-to-prevent-cancer/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
April 11, 2016 - Because aspirin is one of the most extensively studied medications, establishing appropriate exclusion … ‡ Medications include nonaspirin, nonsteroidal anti-inflammatory drugs, and selective serotonin reuptake
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/falls-prevention-in-older-adults-interventions-2018
April 17, 2018 - adaptation or modification of home environment; withdrawal or minimization of psychoactive or other medications
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/carotid-artery-stenosis-screening-december-2007
December 15, 2007 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Recommendation Statement
Carotid Artery Stenosis: Screening, December 2007
December 15, 2007
Recommendations made by the USPSTF are independent of the U.S…
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/depression-screening-1996
January 01, 1996 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Recommendation Statement
Depression: Screening, 1996
January 01, 1996
Recommendations made by the USPSTF are independent of the U.S. government. They sho…
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-b-in-pregnant-women-screening-2009
June 15, 2009 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Recommendation Statement
Hepatitis B in Pregnant Women: Screening
June 15, 2009
Recommendations made by the USPSTF are independent of the U.S. governm…
-
www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/current-processes-refining-evidence-based-recommendation-development-table-1
June 01, 2007 - Current Processes: Refining Evidence-based Recommendation Development - Table 1
Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Table 1. Procedures for Developing a Recommendation Statement a
Activity b
Responsib…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/wAvC6HSumLETsanNkHHXu9
April 01, 2011 - Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: USPSTF Reaffirmation Recommendation Statement
1
Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum:
U.S. Preventive Services Task Force Reaffirmation Recommendation
Statement
SUMMARY OF RECOMMENDATION AND EVIDENCE
The USPSTF recommends prop…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Z3EFdR3PjZKxrRs783_XKH
Substance Abuse Screening Instrument (O4/05)
The Drug Abuse Screening Test (DAST) was developed in 1982 and is still an excellent screening tool. It is a 28-item self-report
scale that consists of items that parallel those of the Michigan Alcoholism Screening Test (MAST). The DAST has “exhibited valid
psychometric pr…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/TzddJozNQQZYmTohr64wMz
June 07, 2016 - These inclusion criteria reflect the scope of the USPSTF recom-
mendations regarding technologies and medications